Exemestane Tablet
Product Images NDC 68382-383

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 68382-383). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3141272d 8016 4ad6 Ba31 A8a62fde27ce 01

FDA Label Image

3141272d 8016 4ad6 Ba31 A8a62fde27ce 02

3141272d 8016 4ad6 Ba31 A8a62fde27ce 02
This text represents statistical information regarding the survival rates of patients who were treated with either Exemestane or Tamoxifen, with the number of patients and events observed during the study. The proportion surviving is not clearly defined, but the Hazard Ratio (HR) is given with its corresponding confidence interval (95% Cl) and p-value (log-rank). The duration of disease-free survival is indicated in months on the X-axis, while the Y-axis shows the proportion of patients surviving at different time intervals.*
FDA Label Image

3141272d 8016 4ad6 Ba31 A8a62fde27ce 03

3141272d 8016 4ad6 Ba31 A8a62fde27ce 03
Not available.*
FDA Label Image

3141272d 8016 4ad6 Ba31 A8a62fde27ce 04

3141272d 8016 4ad6 Ba31 A8a62fde27ce 04
This is a description of a pharmaceutical product containing Exemestane, a drug used to treat breast cancer in postmenopausal women. The package contains 30 tablets, with each tablet coated and containing 25 mg of the drug. The usual dosage is available in the package insert. The product is child-resistant, and should be stored at a controlled temperature of 20°C to 25°C (68°F to 77°F). It should be kept in a tight container and out of reach of children. The product is manufactured by Cadla Healthcare Ltd and distributed by Zydus Pharmaceuticals (USA) Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.